Effect of Pre-operative Carbohydrate Loading on Return of Bowel Function After Reversal of Ileostomy
1 other identifier
interventional
66
1 country
1
Brief Summary
An ileostomy is a common surgery in which part of the small intestine is brought to the surface of the abdomen to allow waste to leave the body. When it is no longer needed, another operation is performed to reconnect the intestine (ileostomy reversal). Although ileostomy reversal is usually a straightforward procedure, some patients experience a temporary slowing or stopping of bowel function after surgery, called post-operative ileus. This can affect up to 3 out of every 10 patients. Symptoms may include nausea, vomiting, bloating, difficulty eating, and not passing gas or stool. Post-operative ileus occurs because surgery, anesthesia, inflammation, and fluid shifts can temporarily affect how the intestines work. When bowel function takes longer than expected to return, patients may need to stay in the hospital longer and may experience additional stress and discomfort. Enhanced Recovery After Surgery (ERAS) programs are designed to help patients recover more quickly after surgery. One important part of these programs is pre-operative carbohydrate loading, where patients drink a carbohydrate-rich beverage before surgery. Research suggests that this may improve the body's response to surgery, reduce nausea and vomiting, and help bowel function return sooner. At Indus Hospital Karachi, ileostomy reversals are commonly performed, particularly in young and middle-aged patients. Finding ways to reduce post-operative ileus could shorten hospital stays, help patients return to their normal activities sooner, and reduce pressure on healthcare resources.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2026
CompletedFirst Submitted
Initial submission to the registry
June 12, 2026
CompletedFirst Posted
Study publicly available on registry
July 6, 2026
CompletedJuly 6, 2026
June 1, 2026
5 months
June 12, 2026
July 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Episodes of nausea, vomiting
Patients will be assessed post-operatively, for the presence of nausea or vomiting on the 1st, 2nd, 3rd day and 4rth day of surgery. The outcome will be measured by the resident in the ward and via questionnaire
Post operative day 1st, 2nd, 3rd, 4rth day
Interval of hours between end of surgery and passing of flatus, audible gut sounds, tolerance to semi-solid food
Interval of hours between end of surgery and passage of flatus, audible gut sounds, tolerance to semi-solid food will be measured at 12, 24, 36, 48 and 72 hours after surgery. Passage of flatus will documented after asking the patient. Gut sounds will auscultated with the help of Pittman 3 stethoscope by the resident on ward duty. Tolerance to semi solid food will be assessed on the 3rd to 4rth post operative day once the primary surgeon has allowed to do so. All of the data will be entered in a questionnaire to assess the outcome measure.
12, 24, 36, 48, 72 hours
Study Arms (2)
Experimental
EXPERIMENTALParticipants receiving carbohydrate drink pre- operatively
Coontrol
PLACEBO COMPARATORParticipants receiving lemon drink as placebo pre-operatively
Interventions
Pre-operative carbohydrate drink will be given to participants in experimental/ interventional arm
Eligibility Criteria
You may qualify if:
- Age above 18 years
- ASA class 2 and below
You may not qualify if:
- · Evidence of chronic/active intestinal disease
- Post-operative complication/morbidity besides postoperative ileus
- Failure of conservative management at more than 72 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Indus Hospital and Health Network
Karachi, Sindh, 45500, Pakistan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postgraduate trainee
Study Record Dates
First Submitted
June 12, 2026
First Posted
July 6, 2026
Study Start
November 1, 2025
Primary Completion
March 31, 2026
Study Completion
April 15, 2026
Last Updated
July 6, 2026
Record last verified: 2026-06